[
    [
        {
            "time": "",
            "orginal_text": "年度盘点：2018年国内药企发展关键词",
            "features": {
                "keywords": [
                    "年度盘点",
                    "国内药企",
                    "发展关键词"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "年度盘点：2018年国内药企发展关键词",
            "scores": {
                "News_content": "年度盘点：2018年国内药企发展关键词",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "orginal_text": "医疗保健：按疾病诊断相关分组付费试点正式出台",
            "features": {
                "keywords": [
                    "医疗保健",
                    "疾病诊断",
                    "分组付费",
                    "试点出台"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗保健"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "医疗保健：按疾病诊断相关分组付费试点正式出台",
            "scores": {
                "News_content": "医疗保健：按疾病诊断相关分组付费试点正式出台",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "医疗保健：坚守低估值与确定性 荐7股",
            "features": {
                "keywords": [
                    "医疗保健",
                    "低估值",
                    "确定性",
                    "荐股"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗保健"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医疗保健：坚守低估值与确定性 荐7股",
            "scores": {
                "News_content": "医疗保健：坚守低估值与确定性 荐7股",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "午评：沪股通净流入13.55亿 深股通净流入1.84亿",
            "features": {
                "keywords": [
                    "午评",
                    "沪股通",
                    "深股通",
                    "净流入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "午评：沪股通净流入13.55亿 深股通净流入1.84亿",
            "scores": {
                "News_content": "午评：沪股通净流入13.55亿 深股通净流入1.84亿",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物2019年投资策略：创新才是硬道理",
            "features": {
                "keywords": [
                    "医药生物",
                    "投资策略",
                    "创新"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物2019年投资策略：创新才是硬道理",
            "scores": {
                "News_content": "医药生物2019年投资策略：创新才是硬道理",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "orginal_text": "公告隐现重大利好 周五8只个股有望突破大涨",
            "features": {
                "keywords": [
                    "公告",
                    "重大利好",
                    "个股",
                    "大涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "公告隐现重大利好 周五8只个股有望突破大涨",
            "scores": {
                "News_content": "公告隐现重大利好 周五8只个股有望突破大涨",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业:控费改革进程中关注结构性投资机会",
            "features": {
                "keywords": [
                    "医药生物",
                    "控费改革",
                    "结构性投资机会"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业:控费改革进程中关注结构性投资机会",
            "scores": {
                "News_content": "医药生物行业:控费改革进程中关注结构性投资机会",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]